Hospital
South Miami Hospital INC
South Miami Hospital INC was paid $9.33M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoSOUTH MIAMI HOSPITAL INC
SOUTH MIAMI, FL 33143
SOUTH MIAMI, FL 33143
33aNPI1982688230assigned 11/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.33M
24GClaims556,896
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#55 of 163
Median peer was paid$4.77M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,448 | $555K | |
| 2019 | 99,380 | $1.84M | |
| 2020 | 82,951 | $1.05M | |
| 2021 | 125,115 | $1.87M | |
| 2022 | 127,383 | $2.48M | |
| 2023 | 57,784 | $1.19M | |
| 2024incomplete | 16,835 | $358K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 16,788 | 14,530 | $1.53M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.5% | 6,940 | 6,166 | $606K |
| 36415 | Collection of venous blood by venipuncture | 6.3% | 23,584 | 14,948 | $585K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 9,816 | 8,025 | $515K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.1% | 27,045 | 24,018 | $475K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 26,066 | 23,211 | $406K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.3% | 5,966 | 687 | $397K |
| G0378 | Hospital observation service, per hour | 3.5% | 8,252 | 5,463 | $322K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.4% | 3,402 | 2,824 | $314K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 1,853 | 1,620 | $300K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.8% | 2,330 | 1,989 | $261K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 2.5% | 18,794 | 15,901 | $231K |
194 more codes
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.9% | 1,921 | $173K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.8% | 10,091 | $168K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.7% | 1,344 | $159K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 18,387 | $153K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 5,771 | $141K |
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 11,341 | $136K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 978 | $130K |
| 86850 | 1.3% | 4,558 | $124K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 19,081 | $109K |
| 86900 | 1.1% | 4,682 | $102K | |
| 86901 | <1% | 4,379 | $87K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,217 | $87K |
| 80076 | <1% | 6,576 | $71K | |
| 82962 | <1% | 3,542 | $60K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,844 | $57K |
| 87081 | <1% | 12,452 | $56K | |
| 84112 | <1% | 368 | $53K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,200 | $52K |
| 87428 | <1% | 3,513 | $49K | |
| 81003 | <1% | 6,397 | $45K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 21,219 | $45K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,041 | $41K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,161 | $41K |
| 73630 | <1% | 2,001 | $40K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 501 | $40K |
| 87088 | <1% | 6,901 | $39K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,711 | $39K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,018 | $35K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,671 | $34K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 790 | $29K |
| A9270 | Non-covered item or service | <1% | 7,445 | $28K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,119 | $28K |
| 73610 | <1% | 1,487 | $27K | |
| 73562 | <1% | 1,550 | $26K | |
| 87430 | <1% | 12,933 | $24K | |
| 85610 | <1% | 9,295 | $23K | |
| 73130 | <1% | 1,376 | $23K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,485 | $22K |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 1,821 | $21K |
| 80047 | <1% | 1,586 | $21K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 380 | $20K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,523 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,803 | $18K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 230 | $17K |
| 76801 | <1% | 983 | $17K | |
| 81001 | <1% | 9,586 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,570 | $16K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,136 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,490 | $16K |
| 87186 | <1% | 3,397 | $16K | |
| 11043 | <1% | 533 | $15K | |
| 85027 | <1% | 3,974 | $15K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 67 | $15K |
| 81025 | <1% | 5,543 | $14K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,080 | $14K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,612 | $14K |
| 97162 | <1% | 683 | $13K | |
| 72100 | <1% | 770 | $13K | |
| 82947 | <1% | 4,320 | $13K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,634 | $13K |
| 73110 | <1% | 894 | $13K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,278 | $12K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,651 | $12K |
| 73030 | <1% | 935 | $12K | |
| 87807 | <1% | 2,185 | $12K | |
| 82731 | <1% | 52 | $11K | |
| C1769 | Guide wire | <1% | 633 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,392 | $10K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 58 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,799 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,386 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 988 | $9K |
| 84132 | <1% | 1,769 | $9K | |
| 82565 | <1% | 2,910 | $9K | |
| 85730 | <1% | 3,854 | $9K | |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 2,073 | $9K |
| J2704 | Injection, propofol, 10 mg | <1% | 745 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 371 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,920 | $8K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 256 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 893 | $8K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 433 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,159 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 161 | $7K |
| 87040 | <1% | 1,012 | $7K | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 66 | $7K |
| 88307 | <1% | 72 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,706 | $7K |
| 87077 | <1% | 3,825 | $6K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 410 | $6K |
| 84520 | <1% | 2,785 | $6K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 361 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 337 | $6K |
| 87210 | <1% | 645 | $5K | |
| 10060 | <1% | 41 | $5K | |
| 72040 | <1% | 223 | $5K | |
| 84145 | <1% | 547 | $5K | |
| 93970 | <1% | 237 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 845 | $4K |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 81 | $4K |
| 82435 | <1% | 1,692 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 421 | $4K |
| 80061 | Lipid panel | <1% | 1,217 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 477 | $4K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 64 | $4K |
| 80051 | <1% | 1,061 | $4K | |
| 76641 | <1% | 113 | $4K | |
| 82374 | <1% | 1,691 | $4K | |
| 84295 | <1% | 1,729 | $4K | |
| 76775 | <1% | 71 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 155 | $3K |
| 73080 | <1% | 206 | $3K | |
| 82150 | <1% | 757 | $3K | |
| 87486 | <1% | 305 | $3K | |
| 86880 | <1% | 14 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 665 | $3K |
| J3490 | Unclassified drugs | <1% | 585 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 305 | $3K |
| 72131 | <1% | 42 | $2K | |
| 84450 | <1% | 612 | $2K | |
| 97161 | <1% | 158 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 596 | $2K |
| 82977 | <1% | 319 | $2K | |
| 82247 | <1% | 767 | $2K | |
| 84075 | <1% | 555 | $2K | |
| 71250 | <1% | 89 | $2K | |
| 71101 | <1% | 93 | $2K | |
| 84484 | <1% | 5,165 | $2K | |
| 83880 | <1% | 1,145 | $2K | |
| 87147 | <1% | 582 | $2K | |
| 86308 | <1% | 506 | $2K | |
| 83690 | <1% | 3,123 | $2K | |
| 82040 | <1% | 873 | $2K | |
| 73140 | <1% | 73 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,489 | $2K |
| 96376 | <1% | 1,795 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 366 | $2K |
| 85379 | <1% | 449 | $1K | |
| 84703 | <1% | 2,932 | $1K | |
| 83605 | <1% | 2,096 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 744 | $1K |
| 84155 | <1% | 377 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 678 | $1K |
| 87581 | <1% | 83 | $1K | |
| 87205 | <1% | 910 | $1K | |
| 84460 | <1% | 597 | $1K | |
| 90715 | <1% | 586 | $1K | |
| 73502 | <1% | 119 | $937.76 | |
| 83735 | <1% | 2,239 | $903.00 | |
| 99205 | Prolong outpt/office vis | <1% | 72 | $826.45 |
| 80053 | Comprehensive metabolic panel | <1% | 303 | $762.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,393 | $748.97 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 544 | $713.50 |
| 87070 | <1% | 374 | $661.42 | |
| 83540 | <1% | 549 | $633.85 | |
| 84156 | <1% | 40 | $445.22 | |
| 97166 | <1% | 75 | $426.47 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 265 | $371.82 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 155 | $370.26 |
| 88304 | <1% | 76 | $356.59 | |
| 83550 | <1% | 267 | $353.01 | |
| 74018 | <1% | 71 | $334.86 | |
| 93880 | <1% | 29 | $321.88 | |
| 88342 | <1% | 21 | $311.10 | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 27 | $298.39 |
| 84702 | <1% | 1,045 | $279.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 298 | $267.64 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,653 | $225.83 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 378 | $209.83 |
| 75574 | <1% | 19 | $196.27 | |
| 86140 | <1% | 193 | $123.21 | |
| 73590 | <1% | 15 | $109.76 | |
| 83615 | <1% | 78 | $104.01 | |
| 29125 | <1% | 43 | $99.59 | |
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 202 | $98.78 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 19 | $62.18 |
| 82728 | <1% | 381 | $35.36 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | $21.71 |
| 82310 | 0% | 85 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 226 | $0.00 |
| 84550 | 0% | 73 | $0.00 | |
| 82570 | 0% | 30 | $0.00 | |
| 69210 | 0% | 25 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 30 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 89 | $0.00 |
| 85384 | 0% | 28 | $0.00 | |
| 29515 | 0% | 13 | $0.00 | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 0% | 14 | $0.00 |
| 87075 | 0% | 15 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 22 | $0.00 |
| 82077 | 0% | 12 | $0.00 | |
| 82550 | 0% | 25 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUQUETTE, WILLIAM (CHIEF EXECUTIVE OFFICER)